The MD-224 Diaries
Compound 60 has an extremely substantial affinity to MDM2 (Ki < 1 nM), potent mobile activity, and a very good oral pharmacokinetic profile. Compound sixty is effective at accomplishing comprehensive and very long-Long lasting tumor regression in vivo and it is at this time in period I clinical trials for most cancers treatment method.Adhere to the